scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCHEARTFAILURE.113.000539 |
P698 | PubMed publication ID | 24014826 |
P50 | author | Adelino F Leite-Moreira | Q37840717 |
André P. Lourenço | Q42441146 | ||
Inês Falcão-Pires | Q52699695 | ||
Arantxa Gonzalez | Q56192180 | ||
Sara Leite | Q57395511 | ||
Dulce Fontoura | Q84273934 | ||
Carsten Tschöpe | Q90667359 | ||
P2093 | author name string | Nazha Hamdani | |
Wolfgang A Linke | |||
Walter J Paulus | |||
Javier Díez | |||
Begoña López | |||
Peter Moritz Becher | |||
Coen A Ottenheijm | |||
Constantijn Franssen | |||
Luisa Plettig | |||
P433 | issue | 6 | |
P921 | main subject | heart failure | Q181754 |
ejection fraction | Q641303 | ||
Heart failure with preserved ejection fraction | Q3799239 | ||
P304 | page(s) | 1239-1249 | |
P577 | publication date | 2013-09-06 | |
P1433 | published in | Circulation: Heart Failure | Q2865806 |
P1476 | title | Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model | |
P478 | volume | 6 |
Q39310989 | A change of heart: oxidative stress in governing muscle function? |
Q95295045 | A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF |
Q36114343 | A mouse model of heart failure with preserved ejection fraction due to chronic infusion of a low subpressor dose of angiotensin II. |
Q52919323 | A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction. |
Q50865900 | A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. |
Q90122980 | Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction |
Q33565707 | Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction |
Q47648074 | Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction. |
Q37716248 | Age-dependent diastolic heart failure in an in vivo Drosophila model. |
Q93269906 | Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction |
Q90652972 | Alterations in Titin Properties and Myocardial Fibrosis Correlate With Clinical Phenotypes in Hemodynamic Subgroups of Severe Aortic Stenosis |
Q47338830 | An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology |
Q26764971 | Animal models of heart failure with preserved ejection fraction |
Q39137992 | Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. |
Q94570857 | Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction |
Q51545876 | Can Nitrite AMPk Up Sirt-ainty to Treat Heart Failure With Preserved Ejection Fraction? |
Q38542448 | Cardiac Physiology of Aging: Extracellular Considerations. |
Q38790312 | Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib. |
Q38970479 | Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats. |
Q39106973 | Cardiovascular consequences of metabolic syndrome. |
Q92813722 | Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding |
Q49385586 | Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF. |
Q98237619 | Cellular, mitochondrial and molecular alterations associate with early left ventricular diastolic dysfunction in a porcine model of diabetic metabolic derangement |
Q64098202 | Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload |
Q35875059 | Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension |
Q64239235 | Circulating Biomarkers Predicting Longitudinal Changes in Left Ventricular Structure and Function in a General Population |
Q38427211 | Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes |
Q26799594 | Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy |
Q55182135 | Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction. |
Q91027944 | Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model |
Q90103714 | Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction |
Q36503059 | Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction |
Q47722872 | Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study. |
Q35155257 | Emerging importance of oxidative stress in regulating striated muscle elasticity |
Q89763523 | Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat |
Q53641091 | Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart. |
Q47105925 | Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction |
Q38760688 | Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction |
Q53241855 | From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress. |
Q64890054 | Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology. |
Q27000263 | Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies |
Q48247164 | Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine? |
Q50099011 | Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction |
Q37719325 | Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. |
Q41011024 | In vitro model to study the effects of matrix stiffening on Ca2+ handling and myofilament function in isolated adult rat cardiomyocytes. |
Q34995889 | Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodeling |
Q55000702 | Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy. |
Q38664204 | Inflammation - Cause or Consequence of Heart Failure or Both? |
Q90482761 | Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction |
Q38591546 | Intercellular communication lessons in heart failure |
Q26765931 | Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction? |
Q52859813 | Latent ischaemia as a trigger for a circulus vitiosus of inflammation, fibrosis, and stiffness in HFPEF. |
Q92330667 | Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction |
Q43067579 | Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it's not one thing it's another |
Q87789836 | Metabolic Syndrome Is Associated With Impaired Diastolic Function Independently of MRI-Derived Myocardial Extracellular Volume: The MESA Study |
Q57045915 | Molecular and pathophysiological links between heart failure with preserved ejection fraction and type 2 diabetes mellitus |
Q49203906 | Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition". |
Q26800076 | Myocardial hypertrophy and its role in heart failure with preserved ejection fraction |
Q38780883 | Myocardial reverse remodeling: how far can we rewind? |
Q35328760 | Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin |
Q38246170 | New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction |
Q51041886 | Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. |
Q37468729 | Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism. |
Q99555719 | Oxidative Stress and Inflammatory Modulation of Ca2+ Handling in Metabolic HFpEF-Related Left Atrial Cardiomyopathy |
Q54750527 | Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention. |
Q47168770 | Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance |
Q40318979 | Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes |
Q93120821 | Posttranslational modifications of titin from cardiac muscle: how, where, and what for? |
Q37696624 | Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes. |
Q38670275 | Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials |
Q48223158 | Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes. |
Q48261592 | Radiation-induced HFpEF model as a potential tool for the exploration of novel therapeutic targets. |
Q39626663 | Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants |
Q53127213 | Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats. |
Q37116376 | Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness. |
Q46980824 | Right ventricular end-diastolic stiffness heralds right ventricular failure in monocrotaline-induced pulmonary hypertension. |
Q36614556 | SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction |
Q47638072 | Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure |
Q52568928 | Stretch your heart-but not too far: The role of titin mutations in dilated cardiomyopathy. |
Q39310690 | Tampering with springs: phosphorylation of titin affecting the mechanical function of cardiomyocytes |
Q33863759 | Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training. |
Q38815425 | The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions |
Q99710955 | The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model |
Q90039918 | The role of fibroblast - Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease |
Q26765101 | The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction |
Search more.